Evaluation of Australia's varicella vaccination program for children and adolescents

Vaccine

Volumn 31, Issue 10, 2013, Pages 1413-1419

  Ward, Kirsten ^a   Dey, Aditi ^a,b   Hull, Brynley ^a   Quinn, Helen E ^a,b   Macartney, Kristine ^a,b   Menzies, Robert ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Coverage; Immunization; Implementation; Serosurveillance; Varicella

Indexed keywords

CHICKENPOX VACCINE; VARICELLA ZOSTER VACCINE;

ADOLESCENT; ARTICLE; AUSTRALIA; CHICKENPOX; CHILD; CLINICAL EVALUATION; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; IMMUNITY; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEMI STRUCTURED INTERVIEW; SEROPREVALENCE; VACCINATION;

ADOLESCENT; ADULT; AUSTRALIA; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; VACCINATION; YOUNG ADULT;

EID: 84875806745     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.12.052     Document Type: Article

References (51)

1. Chant K.G., Sullivan E.A., Burgess M.A., Ferson M.J., Forrest J.M., Baird L.M., et al. Varicella-zoster virus infection in Australia. Australian New Zealand Journal of Public Health 1998, 22(4):413-418. [Erratum appears in Aust N Z J Public Health 1998 Aug;22(5):630].
2. McIntyre P., Gidding H., Gilmour R., Lawrence G., Hull B., Horby P., et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999-2000. Commun Dis Intell 2002, 26(Suppl.):1-111.
3. Macartney K.K., Beutels P., McIntyre P., Burgess M.A. Varicella vaccination in Australia. J Paediatr Child Health 2005, 41(11):544-552.
4. Gidding H. Australia's national serosurveillance program. N S W Public Health Bull 2003, 14(4-5):90-93.
5. Merck Sharp & Dohme (Australia) Pty Limited. Product Information - Varivax® Refrigerated. 2011. Available online at: [cited 25.10.2011]. http://www.csl.com.au/s1/cs/auhq/1196562765747/Web_Product_C/1196562634546/ProductDetail.htm.
6. GlaxoSmithKline. Varilrix® Product Information. 2010. Available online at: [cited 3.06.2011]. http://www.gsk.com.au/resources.ashx/vaccineproductschilddataproinfo/206/FileName/02BC9E131466766392209B623DBC5915/PI_Varilrix.pdf.
7. National Health and Medical Research Council (NHMRC). The Australian Immunisation Handbook. 8th ed. Canberra: Australian Government; 2003.
8. Marshall H., Ryan P., Roberton D. Uptake of varicella vaccine: a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation. Vaccine 2005, 23(46-47):5389-5397.
9. National Health and Medical Research Council (NHMRC). The Australian Immunisation Handbook. 9th ed. Canberra: Australian Government; 2008.
10. Ward K, Quinn H, McIntyre P. Adolescent school-based vaccination in Australia. Commun Dis Intell 2013; in press.
11. Australian Government Department of Health and Ageing. Immunise Australia Program. 2012. Available online at: [cited 13.12.2013]. http://www.immunise.health.gov.au/.
12. Hull BP, Dey A, Menzies R, McIntyre P. Immunisation coverage annual report. Commun Dis Intell 2013; in press.
13. Leask J., Quinn H.E., Macartney K., Trent M., Massey P., Carr C., et al. Immunisation attitudes, knowledge and practices of health professionals in regional NSW. Aust N Z J Public Health 2008, 32(3):224-229.
14. Macartney K Varicella and herpes zoster: where are we now?. Public Health Association of Australia 13th National Immunisation Conference 2012.
15. National Centre for Immunisation Research and Surveillance (NCIRS). National immunisation program evaluations. 2012. Available online at: [cited 10.02.2012]. http://www.ncirs.edu.au/surveillance/evaluation/index.php.
16. Britten N. Qualitative research: qualitative interviews in medical research. BMJ 1995, 311(6999):251.
17. Lindlof T.R., Taylor B.C. Qualitative communication research methods 2002, Sage, Thousand Oaks, CA. 2nd ed.
18. Maxwell J. Designing a qualitative study. Handbook of applied social research methods 1997, Sage, Thousand Oaks, CA. L. Bickman, D. Rog (Eds.).
19. Moser C. Quota sampling. J R Stat Soc Ser A (Gen) 1952, 115(3):411-423.
20. Neuendorf K.A. The content analysis guidebook 2002, Sage Publications, London.
21. Likert R. A technique for the measurement of attitudes. Arch Psychol 1932, 140:1-55.
22. Hull B.P., Deeks S.L., McIntyre P.B. The Australian Childhood Immunisation Register-a model for universal immunisation registers?. Vaccine 2009, 27(37):5054-5060.
23. Hull B.P., Dey A., Mahajan D., Menzies R., McIntyre P. Immunisation coverage annual report, 2009. Commun Dis Intell 2011, 35(2):132-148.
24. Australian Bureau of Statistics (ABS). Schools, Australia, 2006. Cat. No. 4221.0. Canberra: ABS; 2006.
25. Australian Bureau of Statistics (ABS). Schools, Australia, 2007. Cat. No. 4221.0. Canberra: ABS; 2007.
26. Australian Bureau of Statistics (ABS). Schools, Australia, 2008. Cat. No. 4221.0. Canberra: ABS; 2008.
27. Australian Bureau of Statistics (ABS). Schools, Australia, 2009 (reissue). Cat. No. 4221.0. Canberra: ABS; 2009.
28. Quinn H.E., McIntyre P.B., Backhouse J.L., Gidding H.F., Brotherton J., Gilbert G.L. The utility of seroepidemiology for tracking trends in pertussis infection. Epidemiol Infect 2010, 138(3):426-433.
29. de Ory F., Echevarria J.M., Kafatos G., Anastassopoulou C., Andrews N., Backhouse J., et al. European seroepidemiology network 2: standardisation of assays for seroepidemiology of varicella zoster virus. J Clin Virol 2006, 36(2):111-118.
30. Heininger U., Braun-Fahrländer C., Desgrandchamps D., Glaus J., Grize L., Wutzler P., et al. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity. Pediatr Infect Dis J 2001, 20(8):775-778.
31. Brotherton J., Wang H., Schaffer A., Quinn H., Menzies R., Hull B., et al. Vaccine preventable diseases and vaccination coverage in Australia, 2003-2005. Commun Dis Intell 2007, 31(Suppl.):S1-S152.
32. Wooten K.G., Kolasa M., Singleton J.A., Shefer A. National, state, and local area vaccination coverage among children aged 19-35 months - United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59(36):1171-1177.
33. Centres for Disease Control and Prevention National, state, and urban area vaccination coverage levels among children aged 19-35 months - United States, 2000. MMWR Morb Mortal Wkly Rep 2001; 50(30):637-41.
34. Milledge J.T., Cooper C.D., Woolfenden S. Barriers to immunization: attitudes of general practitioners to varicella, the disease and its vaccine. J Paediatr Child Health 2003, 39(5):368-371.
35. Hull B.P., Lawrence G.L., MacIntyre C.R., McIntyre P.B. Immunisation coverage in Australia corrected for under-reporting to the Australian Childhood Immunisation Register. Aust N Z J Public Health 2003, 27(5):533-538.
36. Trent M. Why are children on the NSW North Coast not being vaccinated against chickenpox?. N S W Public Health Bull 2011, 22(11-12):222-223.
37. Australian Government Strengthening immunisation for children factsheet. 2011. Available online at: [cited 10.02.201]. http://www.fahcsia.gov.au/sa/families/payments/Pages/strengthening_immunisation.aspx.
38. Leask J., Booy R., McIntyre P.B.M.M.R., Wakefield The Lancet: what can we learn?. Med J Aust 2010, 193(1):5-7.
39. Leask J. Vaccination and risk communication: summary of a workshop, Arlington Virginia, USA, 5-6 October 2000. J Paediatr Child Health 2002, 38(2):124-128.
40. British Columbia Centre for Disease Control. Immunisation coverage: school age children. 2010. Available online at: [cited 8.03.2011]. http://www.bccdc.ca/imm-vac/BCImmunizationCov/schoolagecoverage/default.htm.
41. Centers for Disease Control and Prevention (CDC) National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59(32):1018-1023.
42. Perella D., Fiks A.G., Jumaan A., Robinson D., Gargiullo P., Pletcher J., et al. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era. Pediatrics 2009, 123(5):e820-e828.
43. Kelly H., Riddell M.A., Gidding H.F., Nolan T., Gilbert G.L. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 2002, 20(25-26):3130-3136.
44. Gershon A.A., Takahashi M., Seward J. Varicella vaccine. Vaccines 2004, 783-823. W.B. Saunders Company, Pennsylvania. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
45. Sauerbrei A., Wutzler P. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen. J Clin Microbiol 2006, 44(9):3094-3097.
46. Khandaker G., Marshall H., Peadon E., Zurynski Y., Burgner D., Buttery J., et al. Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Arch Dis Child 2011, 96(5):453-456.
47. Nelson M.R., Britt H.C., Harrison C.M. Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine. Med J Aust 2010, 193(2):110-113.
48. Chiu C., Dey A., Wang H., Menzies R., Deeks S., Mahajan D., et al. Vaccine preventable diseases in Australia, 2005-2007. Commun Dis Intell 2010, 34(Suppl.):S1-S167.
49. Centers for Disease Control and Prevention (CDC) Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(RR-04):1-40.
50. Wiese-Posselt M., Hellenbrand W Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation. Euro Surveill 2010, 15(16). pii: 19548.
51. Pharmaceutical Benefits Advisory Committee (PBAC). Public summary document - measles, mumps, rubella and varicella vaccine, powder for injection with diluent syringe, 0.5mL, Priorix-Tetra©. November 2007. Available online at: [cited 6.07.2012]. http://www.health.gov.au/internet/main/publishing.nsf/Content/pbac-psd-measles-nov07.